Skip to main content
. Author manuscript; available in PMC: 2020 May 7.
Published in final edited form as: Ann Intern Med. 2019 Apr 9;170(9):594–603. doi: 10.7326/M18-1715

Appendix Figure 1. Adherence rates among PREVAIL participants receiving combination DAA therapy.

Appendix Figure 1.

Adherence rates and their error bars are model-based estimates; SEs were obtained from the mixed-effects linear models adjusting for site and the 3 stratifying variables. No missing data were observed for this analysis. Error bars represent ± SEs. DAA = direct-acting antiviral; DOT = directly observed therapy; GT = group treatment; PREVAIL = Prevent Resistance Eliminate Virus and Improve Life; SIT = self-administered individual treatment.